These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 9747960

  • 1. Relationship between non-enzymatic glycosylation and changes in serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in patients with type 2 diabetes mellitus.
    Cortizo AM, Lee PD, Cédola NV, Jasper H, Gagliardino JJ.
    Acta Diabetol; 1998 Jul; 35(2):85-90. PubMed ID: 9747960
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM, Jehle DR, Mohan S, Böhm BO.
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [Abstract] [Full Text] [Related]

  • 3. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
    Janssen JA, Jacobs ML, Derkx FH, Weber RF, van der Lely AJ, Lamberts SW.
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
    [Abstract] [Full Text] [Related]

  • 4. Advanced glycosylation end products (AGEs), insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with type 2 diabetes mellitus.
    Garay-Sevilla ME, Nava LE, Malacara JM, Wróbel K, Wróbel K, Pérez U.
    Diabetes Metab Res Rev; 2000 Sep; 16(2):106-13. PubMed ID: 10751750
    [Abstract] [Full Text] [Related]

  • 5. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
    Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H.
    Diabetes Metab Res Rev; 1999 Sep; 15(5):314-22. PubMed ID: 10585616
    [Abstract] [Full Text] [Related]

  • 6. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
    Benbassat CA, Maki KC, Unterman TG.
    J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
    [Abstract] [Full Text] [Related]

  • 7. Insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBP-1, -2 and -3) in diabetic pregnancy: relationship to macrosomia.
    Yan-Jun L, Tsushima T, Minei S, Sanaka M, Nagashima T, Yanagisawa K, Omori Y.
    Endocr J; 1996 Apr; 43(2):221-31. PubMed ID: 9026269
    [Abstract] [Full Text] [Related]

  • 8. Serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in children with insulin-dependent diabetes mellitus.
    Cinaz P, Kendirci M, Kurtoglu S, Gökçora N, Buyan N, Yavuz I, Demir A.
    J Pediatr Endocrinol Metab; 1996 Apr; 9(4):475-82. PubMed ID: 8910817
    [Abstract] [Full Text] [Related]

  • 9. Effect of obesity and glycemic control on serum lipocalins and insulin-like growth factor axis in type 2 diabetic patients.
    El-Mesallamy HO, Hamdy NM, Sallam AA.
    Acta Diabetol; 2013 Oct; 50(5):679-85. PubMed ID: 22307870
    [Abstract] [Full Text] [Related]

  • 10. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
    Akturk M, Arslan M, Altinova A, Ozdemir A, Ersoy R, Yetkin I, Ayvali E, Gonen S, Toruner F.
    Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
    [Abstract] [Full Text] [Related]

  • 11. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone.
    Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB.
    Int J Obes Relat Metab Disord; 1997 May; 21(5):355-9. PubMed ID: 9152736
    [Abstract] [Full Text] [Related]

  • 12. Decreased Serum IGF-1/IGFBP-3 Molar Ratio is Associated with Executive Function Behaviors in Type 2 Diabetic Patients with Mild Cognitive Impairment.
    Huang R, Wang P, Han J, Xia W, Cai R, Sun H, Sun J, Wang S.
    J Alzheimers Dis; 2015 May; 47(1):85-94. PubMed ID: 26402757
    [Abstract] [Full Text] [Related]

  • 13. Growth and insulin-like growth factors (IGFs) in children with insulin-dependent diabetes mellitus at the onset of disease: evidence for normal growth, age dependency of the IGF system alterations, and presence of a small (approximately 18-kilodalton) IGF-binding protein-3 fragment in serum.
    Cianfarani S, Bonfanti R, Bitti ML, Germani D, Boemi S, Chiumello G, Boscherini B.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4162-7. PubMed ID: 11095448
    [Abstract] [Full Text] [Related]

  • 14. Serum insulin-like growth factor II levels in normal adolescents and those with insulin dependent diabetes mellitus.
    Acerini CL, Clayton KL, Hintz R, Baker B, Watts A, Holly JM, Dunger DB.
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):13-9. PubMed ID: 8796133
    [Abstract] [Full Text] [Related]

  • 15. Effects of cholinergic modulation on serum insulin-like growth factor-I and its binding proteins in normal and diabetic subjects.
    Ismail IS, Miell JP, Scanlon MF, Peters JR.
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):147-52. PubMed ID: 7535669
    [Abstract] [Full Text] [Related]

  • 16. Insulin-like growth factor binding proteins in prepubertal children with insulin-dependent diabetes mellitus.
    Knip M, Tapanainen P, Pekonen F, Blum WF.
    Eur J Endocrinol; 1995 Oct; 133(4):440-4. PubMed ID: 7581967
    [Abstract] [Full Text] [Related]

  • 17. Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study.
    Drogan D, Schulze MB, Boeing H, Pischon T.
    Am J Epidemiol; 2016 Mar 15; 183(6):553-60. PubMed ID: 26880678
    [Abstract] [Full Text] [Related]

  • 18. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A, Svensson D, Schuett B, Osterziel KJ, Ranke MB.
    Growth Horm IGF Res; 2008 Dec 15; 18(6):506-16. PubMed ID: 18550406
    [Abstract] [Full Text] [Related]

  • 19. Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF).
    Brausewetter F, Jehle PM, Jung MF, Boehm BO, Brueckel J, Hombach V, Osterhues HH.
    Horm Metab Res; 2001 Dec 15; 33(12):713-20. PubMed ID: 11753756
    [Abstract] [Full Text] [Related]

  • 20. Growth promoting peptides in diabetic and non-diabetic pregnancy: interactions with trophoblastic receptors and serum carrier proteins.
    Culler FL, Tung RF, Jansons RA, Mosier HD.
    J Pediatr Endocrinol Metab; 1996 Dec 15; 9(1):21-9. PubMed ID: 8887130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.